242 related articles for article (PubMed ID: 34176503)
1. Regression models for predicting physical and EQD
Wang H; Zhou Y; Gan W; Chen H; Huang Y; Duan Y; Feng A; Shao Y; Gu H; Kong Q; Xu Z
Radiat Oncol; 2021 Jun; 16(1):119. PubMed ID: 34176503
[TBL] [Abstract][Full Text] [Related]
2. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
[No Abstract] [Full Text] [Related]
3. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
5. Fully automated VMAT treatment planning for advanced-stage NSCLC patients.
Della Gala G; Dirkx MLP; Hoekstra N; Fransen D; Lanconelli N; van de Pol M; Heijmen BJM; Petit SF
Strahlenther Onkol; 2017 May; 193(5):402-409. PubMed ID: 28314877
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
[TBL] [Abstract][Full Text] [Related]
7. Dose escalation for locally advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost.
Weiss E; Fatyga M; Wu Y; Dogan N; Balik S; Sleeman W; Hugo G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):414-9. PubMed ID: 23523321
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
Zhong H; Siddiqui SM; Movsas B; Chetty IJ
Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
[TBL] [Abstract][Full Text] [Related]
9. Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer.
Bai X; Shan G; Chen M; Wang B
Biomed Eng Online; 2019 Oct; 18(1):101. PubMed ID: 31619263
[TBL] [Abstract][Full Text] [Related]
10. SBRT combined with concurrent chemoradiation in stage III NSCLC: Feasibility study of the phase I Hybrid trial.
Peulen H; Franssen G; Belderbos J; van der Bijl E; Tijhuis A; Rossi M; Sonke JJ; Damen E
Radiother Oncol; 2020 Jan; 142():224-229. PubMed ID: 31431387
[TBL] [Abstract][Full Text] [Related]
11. Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer.
Miao J; Yan H; Tian Y; Ma P; Liu Z; Li M; Ren W; Chen J; Zhang Y; Dai J
J Appl Clin Med Phys; 2017 Nov; 18(6):169-176. PubMed ID: 29024297
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy.
Sanford L; Molloy J; Kumar S; Randall M; McGarry R; Pokhrel D
J Appl Clin Med Phys; 2019 Jan; 20(1):118-127. PubMed ID: 30548205
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
[TBL] [Abstract][Full Text] [Related]
14. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
Shang H; Pu Y; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
[TBL] [Abstract][Full Text] [Related]
15. An isotoxic planning comparison study for stage II-III non-small cell lung cancer: is intensity-modulated radiotherapy the answer?
Warren M; Webster G; Ryder D; Rowbottom C; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):461-7. PubMed ID: 24793504
[TBL] [Abstract][Full Text] [Related]
16. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
[TBL] [Abstract][Full Text] [Related]
17. Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT.
Pokhrel D; Sanford L; Halfman M; Molloy J
J Appl Clin Med Phys; 2019 May; 20(5):55-63. PubMed ID: 30955251
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
[TBL] [Abstract][Full Text] [Related]
19. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
20. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
